Core Viewpoint - The company will hold an investor briefing on August 21, 2025, to discuss its 2025 semi-annual report and address common investor concerns [2][3][4]. Group 1: Meeting Details - The investor briefing is scheduled for August 21, 2025, from 15:00 to 16:00 [4]. - The meeting will take place at the Shanghai Stock Exchange Roadshow Center and will be conducted in an online text interaction format [4][5]. - Investors can submit questions from August 14 to August 20, 2025, through the Roadshow Center website or via the company's email [2][5]. Group 2: Participants - Key participants in the meeting will include the company's Chairman, independent directors, President, CFO, and Secretary of the Board [4]. Group 3: Participation Method - Investors can join the briefing online on the specified date and time, and the company will respond to questions in real-time [5]. - Investors are encouraged to pre-submit questions to facilitate the discussion during the meeting [5]. Group 4: Contact Information - For inquiries, investors can contact the company representatives via phone or email [6][7].
健民药业集团股份有限公司 关于召开2025年半年度业绩说明会的公告